Tokameh Mahmoudi

Title: Tokameh Mahmoudi: Innovator in Antiviral Research

Introduction

Tokameh Mahmoudi is a notable inventor based in Rotterdam, Netherlands. He has made significant contributions to the field of antiviral research, particularly in the treatment of coronavirus and HIV. With a total of 2 patents, his work focuses on innovative methods to combat viral infections.

Latest Patents

Mahmoudi's latest patents include groundbreaking inventions aimed at addressing critical health challenges. One of his patents is titled "Substituted antivirals for treating coronavirus infection." This invention provides a BAF complex modulating compound for use as a coronavirus antiviral, specifically designed to modulate the BAF complex. Another significant patent is "Methods for reversing HIV latency using BAF complex modulating compounds." This disclosure outlines methods of using BAF complex modulating compounds as inhibitors of BAF-mediated transcription in target cells. The compounds include 12-membered macrolactam compounds that target a BAF-specific subunit, such as ARID1A, to prevent nucleosomal positioning and relieve transcriptional repression of HIV-1.

Career Highlights

Throughout his career, Tokameh Mahmoudi has worked with esteemed institutions, including Erasmus University Medical Center and Purdue Research Foundation. His research has focused on developing innovative solutions for viral infections, showcasing his commitment to advancing medical science.

Collaborations

Mahmoudi has collaborated with notable colleagues, including Emily Carla Dykhuizen and Bartholomeus Leonardus Haagmans. These collaborations have contributed to the advancement of his research and the development of his patents.

Conclusion

Tokameh Mahmoudi is a distinguished inventor whose work in antiviral research has the potential to make a significant impact on public health. His innovative patents reflect his dedication to finding effective treatments for viral infections.